Foresite Capital Management V LLC Sells 77,094 Shares of Compass Therapeutics, Inc. (NASDAQ:CMPX)

Foresite Capital Management V LLC lowered its stake in shares of Compass Therapeutics, Inc. (NASDAQ:CMPX – Free Report) by 5.8% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,246,977 shares of the company’s stock after selling 77,094 shares during the quarter. […]

Related Keywords

,Blackrock Inc ,York Mellon Corp ,Vanguard Group Inc ,Nasdaq ,Compass Therapeutics Inc ,Renaissance Technologies ,Marshall Wace ,Foresite Capital Management ,Exchange Commission ,Compass Therapeutics ,Free Report ,New York Mellon Corp ,Vanguard Group ,Therapeutics Trading Down ,Visit Holdingschannel ,Compass Therapeutics Daily ,Nasdaq Cmpx ,Cmpx ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,